Journal of Personalized Medicine · 2 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This paper is a narrative report on the Synchrony 2022 conference, which convened researchers, clinicians, and industry experts to discuss translational research and challenges in treating autism spectrum disorder (ASD) and other neurodevelopmental disorders. The central result is the identification of key knowledge gaps and the formation of working groups to produce consensus guidance on topics like neuroinflammation, biomarkers, and ASD/epilepsy.
The paper summarizes the Synchrony 2022 conference, a three-day event focused on accelerating the translation of autism spectrum disorder (ASD) research into treatments. The conference featured academic and industry sessions, along with four roundtables. These roundtables identified significant knowledge gaps and convened panels to address them: one on the under-researched role of neuroinflammation in ASD behavioral exacerbations, another on the challenges of FDA drug development pipelines, a third on diagnostic and treatment biomarkers for ASD, and a fourth on the intersection of ASD and epilepsy. The panels agreed to develop consensus articles and guidelines on these topics.
